Navigating GLP-1s and the Battle to Address Obesity and Cardiometabolic Disease -- Attendee Pre-Program Survey

Question Title

* 1. What are your biggest concerns about the use of GLP-1s for your workforce? Please Rank order the following statements

Question Title

* 2. Please indicate your level of agreement with each statement.

	Strongly Agree	Agree	Somewhat Agree	Disagree	Strongly Disagree
Weight loss is a challenge that each person needs to address/pay for themselves	Weight loss is a challenge that each person needs to address/pay for themselves Strongly Agree	Weight loss is a challenge that each person needs to address/pay for themselves Agree	Weight loss is a challenge that each person needs to address/pay for themselves Somewhat Agree	Weight loss is a challenge that each person needs to address/pay for themselves Disagree	Weight loss is a challenge that each person needs to address/pay for themselves Strongly Disagree
People who are obese should have access to whatever medical/behavioral science can offer	People who are obese should have access to whatever medical/behavioral science can offer Strongly Agree	People who are obese should have access to whatever medical/behavioral science can offer Agree	People who are obese should have access to whatever medical/behavioral science can offer Somewhat Agree	People who are obese should have access to whatever medical/behavioral science can offer Disagree	People who are obese should have access to whatever medical/behavioral science can offer Strongly Disagree
Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s.	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Strongly Agree	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Agree	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Somewhat Agree	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Disagree	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Strongly Disagree
GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Strongly Agree	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Agree	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Somewhat Agree	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Disagree	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Strongly Disagree

Question Title

* 3. What are your questions related to addressing obesity?

Question Title

* 4. Please share your experiences and/or questions about the efficacy of GLP-1s.

Question Title

* 5. Please share your experiences and/or questions about the cost of GLP-1s.

Question Title

* 6. Please share which solutions you are using to gate or support GLP-1s as part of your plans for addressing obesity/cardiometabolic risk.